AL
REGN icon

Airain Ltd’s Regeneron Pharmaceuticals REGN Stock Holding History

Airain Ltd’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-14,461
Closed -$5.31M – 956
2016
Q4 		$5.31M Buy
+14,461
New +$5.5M 0.43% 60
2016
Q3 		– Sell
-56,153
Closed -$19.6M – 769
2016
Q2 		$19.6M Buy
56,153
+50,895
+968% +$19.6M 1.13% 8
2016
Q1 		$1.9M Sell
5,258
-23,140
-81% -$9.54M 0.13% 182
2015
Q4 		$15.4M Sell
28,398
-5,710
-17% -$3.09M 1.06% 5
2015
Q3 		$15.9M Buy
34,108
+30,457
+834% +$16.4M 0.95% 6
2015
Q2 		$1.86M Sell
3,651
-18,044
-83% -$8.81M 0.1% 223
2015
Q1 		$9.79M Sell
21,695
-2,103
-9% -$891K 0.6% 38
2014
Q4 		$9.76M Sell
23,798
-1,879
-7% -$739K 0.8% 22
2014
Q3 		$9.26M Buy
25,677
+15,298
+147% +$5.13M 0.63% 21
2014
Q2 		$2.93M Buy
+10,379
New +$3.08M 0.24% 108
2014
Q1 		– Sell
-17,119
Closed -$4.71M – 845
2013
Q4 		$4.71M Buy
+17,119
New +$4.92M 0.61% 39

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Airain Ltd's REGN Position: Q1 2017 in Review

Airain Ltd sold out of Regeneron Pharmaceuticals (REGN) in Q1 2017, closing a stake of 14,461 shares — an estimated $5.31M sold.

Airain Ltd first reported a position in REGN in Q4 2013 and held it in 11 quarters. The position peaked at $19.6M in Q2 2016. 578 funds tracked by Wall St. Rank hold REGN as of Q1 2017.

  • Airain Ltd reported no remaining Regeneron Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Airain Ltd sold 14,461 Regeneron Pharmaceuticals shares in Q1 2017, an estimated $5.31M.
  • Airain Ltd first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 11 quarters.
  • Airain Ltd's Regeneron Pharmaceuticals position peaked at $19.6M in Q2 2016.
  • 578 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2017.

Based on Airain Ltd's 13F filing for Q1 2017, filed 9 May 2017.